MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Erratum for Ayoub et al., Mol Pharmacol 66 (2) 312-321.
0026-895X/04/6603-771-$20.00
Mol Pharmacol 66:771-, 2004

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content
Correction

Correction to "Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers"

In the above article [Ayoub MA, Levoye A, Delagrange P, and Jockers R (2004) Mol Pharmacol 66:312–321], information regarding the ligands in Fig. 5 was removed in error during copyediting. A corrected version of Fig. 5 appears below. The online version has been corrected in departure from the print version.



View larger version (24K):
[in this window]
[in a new window]
 
Fig. 5. Correlations between EC50 values of MT1/MT2 heterodimers and Ki values of MT1 and MT2 receptors. EC50 values of the MT1/MT2 heterodimer shown in Table 4 were plotted against Ki values determined in cells coexpressing MT1 and MT2 receptors (A) or expressing MT1-Rluc (B) or MT2-YFP (C) receptors individually. D, correlation between EC50 values of the MT2 homodimer and the MT1/MT2 heterodimer. Ligands: 1, melatonin; 2, S20098 [GenBank] ; 3, S22153 [GenBank] ; 4, S20928; 5, 4P-PDOT; 6, luzindole; 7, S24773; 8, 2-iodomelatonin. B and C, nonselective () and selective ({circ}) compounds. Ligand 9 shown in B corresponds to the MT1-selective S26284 [GenBank] compound. Data were fitted using a linear regression equation (GraphPad Prism software).

 

We regret this error and apologize for any confusion or inconvenience it may have caused.





This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Search for Related Content


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2004 by the American Society for Pharmacology and Experimental Therapeutics